# EDGAR Filing Document

**Accession Number:** 0001833124
**File Stem:** 0001213900-26-001394
**Filing Date:** 2026-1
**Character Count:** 15595
**Document Hash:** 798831c3f11f585d250194a41de328d7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-001394.hdr.sgml**: 20260105

**ACCESSION NUMBER**: 0001213900-26-001394

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20251230

**FILED AS OF DATE**: 20260105

**DATE AS OF CHANGE**: 20260105

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Manieu Alexandre Weinstein
- **CENTRAL INDEX KEY:** 0001833124

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31392
- **FILM NUMBER:** 26508879

**MAIL ADDRESS:**
- **STREET 1:** CHASHAM PLACE
- **STREET 2:** FLAT 1
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** SW1X 8HG
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Chutzpah Holdings Ltd
- **CENTRAL INDEX KEY:** 0002055515

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** Y9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31392
- **FILM NUMBER:** 26508878

**BUSINESS ADDRESS:**
- **STREET 1:** 4TH FLOOR, LIBERATION HOUSE
- **STREET 2:** CASTLE STREET
- **CITY:** ST HELIER
- **STATE:** Y9
- **ZIP:** JE1 4HH
- **BUSINESS PHONE:** 44-1534-823126

**MAIL ADDRESS:**
- **STREET 1:** 4TH FLOOR, LIBERATION HOUSE
- **STREET 2:** CASTLE STREET
- **CITY:** ST HELIER
- **STATE:** Y9
- **ZIP:** JE1 4HH
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Pluri Inc.
- **CENTRAL INDEX KEY:** 0001158780
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 980351734
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** MATAM ADVANCED TECHNOLOGY PARK
- **STREET 2:** BUILDING NO. 5
- **CITY:** HAIFA
- **PROVINCE COUNTRY:** L3
- **BUSINESS PHONE:** 972-74-710-7171

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** MATAM ADVANCED TECHNOLOGY PARK
- **STREET 2:** BUILDING NO. 5
- **CITY:** HAIFA
- **PROVINCE COUNTRY:** L3

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PLURISTEM THERAPEUTICS INC
- **DATE OF NAME CHANGE:** 20071228

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PLURISTEM LIFE SYSTEMS INC
- **DATE OF NAME CHANGE:** 20030701

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AI SOFTWARE INC
- **DATE OF NAME CHANGE:** 20010906

## Exhibit 99.1

**Exhibit 1**

**INFORMATION REGARDING JOINT FILERS**

Designated Filer of Form 3, Form 4: Alexandre Weinstein Manieu, Chutzpah Holdings Limited

Date of Earliest Transaction Required to be Reported: December 30, 2025

Issuer Name and Ticker Symbol: **Pluri Inc. (PLUR)**

Information

---

| | |
|:---|:---|
| &nbsp;&nbsp;Name | &nbsp;&nbsp;Address |
| &nbsp;&nbsp;Chutzpah Holdings LP | &nbsp;&nbsp;337 Winston Road Oakville, Ontario (CA-ON), L6l 4w6 Canada |
| &nbsp;&nbsp;Chutzpah Holdings Limited | &nbsp;&nbsp; 4<sup>th</sup> Floor, Liberation House, Castle Street<br> St. Helier, Jersey Islands, JE1 4HH |
| &nbsp;&nbsp;Plantae Bioscience Ltd. | &nbsp;&nbsp;Yarkon 5, Floor 10, Bnei Brak 5120125, Israel |
| &nbsp;&nbsp;Alexandre Weinstein Manieu | &nbsp;&nbsp; Apt 8002<br> Bürgenstock Hotels & Resort<br> Bürgenstock 30<br> 6363 Obbürgen<br> Switzerland |

---

The undersigned, Alexandre "Alejandro" Weinstein Manieu, Chutzpah Holdings Limited, Chutzpah Holdings LP and Plantae Bioscience Ltd. are jointly filing the attached Statement of Changes in Beneficial Ownership of Securities on Form 4 with respect to the beneficial ownership of securities of Pluri Inc.

---

| |
|:---|
| **ALEXANDRE WEINSTEIN MANIEU** |
| /s/ Alexandre Weinstein Manieu |

---

---

| | |
|:---|:---|
| **CHUTZPAH HOLDINGS LIMITED** | **CHUTZPAH HOLDINGS LIMITED** |
| By: | /s/ Ana Ventura |
| Name: | Ana Ventura |
| Title: | Authorized Officer<br> Beaumont (Directors) Limited,<br> Sole Corporate Director |
| By: | /s/ Karen Oliver |
| Name: | Karen Oliver |
| Title: | Authorized Officer<br> Beaumont (Directors) Limited,<br> Sole Corporate Director |

---

---

| | |
|:---|:---|
| **CHUTZPAH HOLDINGS LP** | **CHUTZPAH HOLDINGS LP** |
| By: | /s/ Alexandre Weinstein |
| Name: | Alexandre Weinstein |
| Title: | Authorized Signatory<br>|
| **PLANTAE BIOSCIENCE LTD.** | **PLANTAE BIOSCIENCE LTD.** |
| By: | /s/ Eli Mor |
| Name: | Eli Mor |
| Title: | Authorized Signatory |

---

## Exhibit 99.2

**Exhibit 2**

**JOINT FILING AGREEMENT**

This joint filing agreement (this "**Agreement**") is made and entered into by and between Alexandre Weinstein Manieu, Chutzpah Holdings Limited, Chutzpah Holdings LP and Plantae Bioscience Ltd.

The parties to this Agreement hereby agree to prepare jointly and file timely (and otherwise to deliver as appropriate) all filings on any Form 3, Form 4, Form 5 or Schedule 13D or Schedule 13G, and any and all amendments thereto and any other document relating thereto (collectively, the "**Filings**") required to be filed by them pursuant to the Securities Exchange Act of 1934, as amended (the "**Exchange Act**"). Each party to this Agreement further agrees and covenants to the other parties that it will fully cooperate with such other parties in the preparation and timely filing (and other delivery) of all such Filings.

This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument.

**IN WITNESS WHEREOF**, the undersigned hereby execute this Joint Filing Agreement as of the 5<sup>th</sup> day of January, 2026.

---

| |
|:---|
| **ALEXANDRE WEINSTEIN MANIEU** |
| /s/ Alexandre Weinstein Manieu |

---

---

| | |
|:---|:---|
| **CHUTZPAH HOLDINGS LIMITED** | **CHUTZPAH HOLDINGS LIMITED** |
| By: | /s/ Ana Ventura |
| Name: | Ana Ventura |
| Title: | Authorized Officer<br> Beaumont (Directors) Limited,<br> Sole Corporate Director |

---

---

| | |
|:---|:---|
| **CHUTZPAH HOLDINGS LIMITED** | **CHUTZPAH HOLDINGS LIMITED** |
| By: | /s/ Karen Oliver |
| Name: | Karen Oliver |
| Title: | Authorized Officer<br> Beaumont (Directors) Limited,<br> Sole Corporate Director |

---

---

| | |
|:---|:---|
| **CHUTZPAH HOLDINGS LP** | **CHUTZPAH HOLDINGS LP** |
| By: | /s/ Alexandre Weinstein |
| Name: | Alexandre Weinstein |
| Title: | Authorized Signatory |

---

---

| | |
|:---|:---|
| **PLANTAE BIOSCIENCE LTD.** | **PLANTAE BIOSCIENCE LTD.** |
| By: | /s/ Eli Mor |
| Name: | Eli Mor |
| Title: | Authorized Signatory |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Manieu Alexandre Weinstein<br><sub>(Last) (First) (Middle)</sub><br>APT 8002, BURGENSTOCK HOTELS & RESORT,<br>BURGENSTOCK 30<br><sub>(Street)</sub><br>OBBURGEN, V8 6363<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-12-30 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Pluri Inc. [ PLUR ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Chutzpah Holdings Ltd<br><sub>(Last) (First) (Middle)</sub><br>4TH FLOOR, LIBERATION HOUSE<br>CASTLE STREET<br><sub>(Street)</sub><br>ST. HELIER, Y9 JE1 4HH<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-12-30 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Pluri Inc. [ PLUR ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-12-08 |  | A |  | 625000 | A | $2.00 | 625000<sup>(1)(2)</sup> | I | Shares indirectly held through Chutzpah Holdings LP<sup>(3)</sup> |
| Common Stock |  |  |  |  |  |  |  | 452702 | I | Shares indirectly held through Plantae Bioscience Ltd.<sup>(4)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Warrants | $4.25 | 2025-12-08 |  | A |  | 625000 |  | 2025-12-08 | 2026-06-30 | Common Shares | 625000 | $2.00 | 625000<sup>(1)(2)</sup> | I | Warrants indirectly held through Chutzpah Holdings LP<sup>(3)</sup> |

---

### Footnotes:

(1) On December 8, 2025, Pluri Inc. (the "Company") entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with Chutzpah Holdings LP, a limited partnership beneficially owned by Mr. Alexandre Weinstein, a non-U.S. investor and an existing shareholder and director of the Company ("Mr. Weinstein"), relating to a private placement offering (the "Offering") of: (i) 625,000 common shares, par value $01 per share (the "Common Shares") of the Company, and (ii) warrants (the "Common Warrants") to purchase up to 625,000 Common Shares. The combined purchase price for each Common Share and Common Warrant is $4.00.

(2) (Continuation of Footnote 1) The Common Warrants will be exercisable immediately at an exercise price of $4.25 per share and will be exercisable until June 30, 2026. The Common Warrants contain customary anti-dilution provisions and are subject to a 35% beneficial ownership limitation. The Securities Purchase Agreement contains customary representations, warranties and indemnification obligations of the parties.

(3) This statement is jointly filed by and on behalf of each of Chutzpah Holdings LP ("CHLP"), Chutzpah Holdings Limited ("CHL"), Plantae Bioscience Ltd. ("Plantae") and Mr. Weinstein. Mr. Weinstein indirectly owns 100% of Chutzpah and may be deemed to beneficially own securities owned by Chutzpah. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities.

(4) Mr. Weinstein indirectly owns approximately 78.32% of PBL and may be deemed to beneficially own securities owned by PBL. Neither the filing of this statement nor anything herein shall be deemed an admission that Mr. Weinstein is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities owned by PBL. Mr. Weinstein disclaims beneficial ownership of such securities covered by this statement, except to the extent of his pecuniary interest in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

**Remarks:**
Exhibit Index: Exhibit 1 - Joint Filer Information. Exhibit 2 - Joint Filing Agreement dated January 5, 2026. Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

**Signature:** /s/ Alexandre Weinstein Manieu  
**Date:** 2026-01-05

**Signature:** /s/ Ana Ventura Authorized Officer For Beaumont (Directors) Limited Sole Corporate Director  
**Date:** 2026-01-05

**Signature:** /s/ Karen Oliver Authorized Officer For Beaumont (Directors) Limited Sole Corporate Director  
**Date:** 2026-01-05

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**